W

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Business Management
Share
Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Polymarket suspends trading after third-party breach leads to user losses

Polymarket said one of its thirdparty providers was breached after users reported seeing their accounts drained. Source：CoinDesk

Did the Fed make a mistake with its October rate pause? The Treasury could help save the day.

As focus shifts to the Treasury’s funding plans, there’s some expectation that longerterm supply could be reduced in an attempt to boost demand and lower…

HYPE teases all-time high as NYSE owner ICE eyes US Hyperliquid perps

Hyperliquid’s token pumped following news of ICE and Trade[XYZ] unveiling plans for US perpetual futures. Source：Cointelegraph

KuCoin suspends services in Russia and Belarus

The exchange cited legal and regulatory compliance in its reason for cutting off services to users based in the two countries, currently the targets of…

Source：https://www.marketwatch.com/story/ozempic-maker-novo-nordisk-downgraded-to-sell-after-70-stock-price-dive-from-peak-90193914